News and Views on the SSRI Group of Drugs


  • STOP the Lies: Join the Cause: Click pic below

  • Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 7 other followers

  • Monthly Archive showing # of posts

  • Advertisements

Glaxo, Top Ad Spender, Didn’t Publicize Avandia Risks

Posted by shutah on June 2, 2007

June 1 (Bloomberg)

GlaxoSmithKline Plc was the drug industry’s top advertiser last year, promoting its asthma and diabetes treatments to patients and doctors. Information the company didn’t make well known is now drawing more attention.

London-based Glaxo knew its Avandia diabetes pill posed a risk for heart and circulatory complications as early as 1999, when the medicine won U.S. approval. The cardiovascular concern wasn’t widely disseminated until May 21 when a Cleveland Clinic Foundation analysis reported that Avandia may cause a 43 percent higher risk of heart attacks than other drugs.

When asked …..

“Why would you publicize it?,” Glaxo Chief Executive Officer Jean-Pierre Garnier told reporters at the company’s annual meeting May 23 in London. “We don’t publicize every submission we make to the Food and Drug Administration.”

 Deja Vu ??  

Click here to read the rest of the article.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: